I wish to draw readers’ attention to some new research on the neuropsychiatric side effects of Tamiflu of which I was unaware when my article “Flu Warning: Beware the Drug Companies!” went to press.
In an article dated December 2010 (but published in March 2011), Toshiharu Fujita and colleagues presented a study of 9,386 influenza patients under the age of eighteen. They found that episodes of loss of consciousness were roughly 80 percent more common among those who had taken Tamiflu compared to those who had not.
This article is available to subscribers only.
Please choose from one of the options below to access this article:
Purchase a print subscription (20 issues per year) and also receive online access to all articles published within the last five years.
Purchase an Online Edition subscription and receive full access to all articles published by the Review since 1963.